Synonym: (−)-(S)-5,6,7,8-Tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-1-naphthol hydrochloride; (−)-N 0437; N 0923; Neupro; SPM 962
CAS Number: 125572-93-2
Empirical Formula (Hill Notation): C19H25NOS·HCl
Molecular Weight: 351.93
MDL Number: MFCD00906149
Linear Formula: C19H25NOS·HCl
Product Type: Chemical
| API family |
rotigotine |
| format |
neat |
| grade |
pharmaceutical primary standard |
| InChI |
1S/C19H25NOS.ClH/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21;/h3-7,13,16,21H,2,8-12,14H2,1H3;1H/t16-;/m0./s1 |
| InChI key |
CEXBONHIOKGWNU-NTISSMGPSA-N |
| manufacturer/tradename |
EDQM |
| SMILES string |
Cl.CCCN(CCc1cccs1)[C@H]2CCc3c(O)cccc3C2 |
| storage temp. |
2-8°C |
| Application: |
Rotigotine hydrochloride EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia. |
| Biochem/physiol Actions: |
Rotigotine is a dopamine receptor agonist with preference for D3 receptors over D2 and D1. As such, it is an effective anti-Parkinsonian agent. Racemic rotigotine is about 50 times as potent as quinpirole, the gold standard D2 agonist. |
| General description: |
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia   . |
| Other Notes: |
Sales restrictions may apply. |
| Packaging: |
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue . |
| WGK Germany |
WGK 2 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Storage Temp. |
2-8°C |
| UNSPSC |
41116107 |
